Skip to main content
Top
Published in: BMC Women's Health 1/2017

Open Access 01-12-2017 | Research article

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis

Authors: Bicheng Yang, Liqun Wang, Xiaoju Wan, Yunjun Li, Xiaohong Yu, Yunna Qin, Yong Luo, Feng Wang, Ouping Huang

Published in: BMC Women's Health | Issue 1/2017

Login to get access

Abstract

Background

Given the important roles of the receptor-mediated lysophosphatidic acid (LPA) signaling in both reproductive tract function and gynecological cancers, it will be informative to investigate the potential role of LPA in the development of adenomyosis. The objective of this study was to evaluate the levels of LPA in plasma and the expression of six LPA receptors in the endometrial tissue collected from women with and without adenomyosis.

Methods

Plasma and endometrial tissue samples were collected form women with and without adenomyosis. The levels of LPA in plasma were determined by using high-performance liquid chromatography electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS). Immunohistochemistry was performed to evaluate the expression of six LPA receptors (LPA1–6) in endometrial tissue samples. The effects of LPA on IL-8 production, VEGF production and cell proliferation in human endometrial stromal cells (ESCs) were also assessed.

Results

LPA1 staining was localized to the cytoplasm, membrances of the epithelial cells of the endometrial glands, and there was little staining in the stromal cells. LPA2–5 staining were localized to the nuclei of stromal and glandular cells. Plasma levels of LPA were increased in adenomyosis. LPA1, LPA4 and LPA5 immunoreactivity were significantly higher in the adenomyosis group than in the control group, while LPA2 and LPA3 immunoreactivity were significantly lower in the adenomyosis group than in the control group. LPA6 was undetectable in the endometria. LPA induced the release of IL-8 from ESCs but did not affect cell proliferation and VEGF production.

Conclusion

These results indicate that elevated plasma levels of LPA and aberrant expression of LPA receptors in the endometria may be associated with the development of adenomyosis.
Literature
1.
go back to reference Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update. Fertil Steril. 2012;98(3):572–9.CrossRefPubMed Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update. Fertil Steril. 2012;98(3):572–9.CrossRefPubMed
2.
go back to reference Alabiso G, Alio L, Arena S, et al. Adenomyosis: What the Patient Needs. J Minim Invasive Gynecol. 2016;23(4):476–88.CrossRefPubMed Alabiso G, Alio L, Arena S, et al. Adenomyosis: What the Patient Needs. J Minim Invasive Gynecol. 2016;23(4):476–88.CrossRefPubMed
3.
go back to reference Vigano P, Corti L, Berlanda N. Beyond infertility: obstetrical and postpartum complications associated with endometriosis and adenomyosis. Fertil Steril. 2015;104(4):802–12.CrossRefPubMed Vigano P, Corti L, Berlanda N. Beyond infertility: obstetrical and postpartum complications associated with endometriosis and adenomyosis. Fertil Steril. 2015;104(4):802–12.CrossRefPubMed
4.
go back to reference Pustilnik TB, Estrella V, Wiener JR, et al. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res. 1999;5(11):3704–10.PubMed Pustilnik TB, Estrella V, Wiener JR, et al. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res. 1999;5(11):3704–10.PubMed
5.
go back to reference Moolenaar WH. Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem. 1995;270(22):12949–52.CrossRefPubMed Moolenaar WH. Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem. 1995;270(22):12949–52.CrossRefPubMed
6.
go back to reference Fukushima N, Weiner JA, Kaushal D, et al. Lysophosphatidic acid influences the morphology and motility of young, postmitotic cortical neurons. Mol Cell Neurosci. 2002;20(2):271–82.CrossRefPubMed Fukushima N, Weiner JA, Kaushal D, et al. Lysophosphatidic acid influences the morphology and motility of young, postmitotic cortical neurons. Mol Cell Neurosci. 2002;20(2):271–82.CrossRefPubMed
7.
go back to reference Lin ME, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010;91(3–4):130–8.CrossRefPubMed Lin ME, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010;91(3–4):130–8.CrossRefPubMed
8.
go back to reference Woclawek-Potocka I, Rawinska P, Kowalczyk-Zieba I, et al. Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract. Mediat Inflamm. 2014:1–14. Woclawek-Potocka I, Rawinska P, Kowalczyk-Zieba I, et al. Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract. Mediat Inflamm. 2014:1–14.
10.
go back to reference Shan L, Jaffe K, Li S, et al. Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column. J Chromatogr B Analyt Technol Biomed and Life Sci. 2008;864(1–2):22–8.CrossRef Shan L, Jaffe K, Li S, et al. Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column. J Chromatogr B Analyt Technol Biomed and Life Sci. 2008;864(1–2):22–8.CrossRef
11.
go back to reference Wang J, Deng XH, Yang Y, et al. Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis. Fertil Steril. 2016;105(4):1093–101.CrossRefPubMed Wang J, Deng XH, Yang Y, et al. Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis. Fertil Steril. 2016;105(4):1093–101.CrossRefPubMed
12.
go back to reference Tominaga H, Ishiyama M, Ohseto F, et al. A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal Commun. 1999;36(2):47–50.CrossRef Tominaga H, Ishiyama M, Ohseto F, et al. A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal Commun. 1999;36(2):47–50.CrossRef
13.
go back to reference Xu Y, Shen ZZ, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. 1998;280(8):719–23.CrossRefPubMed Xu Y, Shen ZZ, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. 1998;280(8):719–23.CrossRefPubMed
14.
go back to reference Fang XJ, Schummer M, Mao ML, et al. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta. 2002;1582(1–3):257–64.CrossRefPubMed Fang XJ, Schummer M, Mao ML, et al. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta. 2002;1582(1–3):257–64.CrossRefPubMed
15.
go back to reference Wang FQ, Ariztia EV, Boyd LR, et al. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity. Gynecol Oncol. 2010;117(1):88–95.CrossRefPubMed Wang FQ, Ariztia EV, Boyd LR, et al. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity. Gynecol Oncol. 2010;117(1):88–95.CrossRefPubMed
16.
go back to reference Sasagawa T, Okita M, Murakami J, et al. Abnormal serum lysophospholipids in multiple myeloma patients. Lipids. 1999;34(1):17–21.CrossRefPubMed Sasagawa T, Okita M, Murakami J, et al. Abnormal serum lysophospholipids in multiple myeloma patients. Lipids. 1999;34(1):17–21.CrossRefPubMed
17.
go back to reference Tsui KH, Lee FK, Seow KM, et al. Conservative surgical treatment of adenomyosis to improve fertility: controversial values, indications, complications, and pregnancy outcomes. Taiwan J Obstet Gynecol. 2015;54(6):635–40.CrossRefPubMed Tsui KH, Lee FK, Seow KM, et al. Conservative surgical treatment of adenomyosis to improve fertility: controversial values, indications, complications, and pregnancy outcomes. Taiwan J Obstet Gynecol. 2015;54(6):635–40.CrossRefPubMed
18.
go back to reference Campo S, Campo V, Benagiano G. Adenomyosis and infertility. Reprod BioMed Online. 2012;24(1):35–46.CrossRefPubMed Campo S, Campo V, Benagiano G. Adenomyosis and infertility. Reprod BioMed Online. 2012;24(1):35–46.CrossRefPubMed
19.
go back to reference Rivera R, Chun J. Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol. 2008;160:25–46.PubMed Rivera R, Chun J. Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol. 2008;160:25–46.PubMed
20.
go back to reference Murph MM, Nguyen GH, Radhakrishna H, et al. Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation. Biochim Biophys Acta. 2008;1781(9):547–57.CrossRefPubMedPubMedCentral Murph MM, Nguyen GH, Radhakrishna H, et al. Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation. Biochim Biophys Acta. 2008;1781(9):547–57.CrossRefPubMedPubMedCentral
21.
go back to reference Ota H, Igarashi S, Kato N, Tanaka T. Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril. 2000 Aug;74(2):313–8.CrossRefPubMed Ota H, Igarashi S, Kato N, Tanaka T. Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril. 2000 Aug;74(2):313–8.CrossRefPubMed
22.
go back to reference Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol. 1999 Jul;94(1):71–7.PubMed Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol. 1999 Jul;94(1):71–7.PubMed
23.
go back to reference Sotnikova N, Antsiferova I, Malyshkina A. Cytokine network of eutopic and ectopic endometrium in women with adenomyosis. Am J Reprod Immunol. 2002 Apr;47(4):251–5.CrossRefPubMed Sotnikova N, Antsiferova I, Malyshkina A. Cytokine network of eutopic and ectopic endometrium in women with adenomyosis. Am J Reprod Immunol. 2002 Apr;47(4):251–5.CrossRefPubMed
24.
go back to reference Ulukus EC, Ulukus M, Seval Y, et al. Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis. Hum Reprod. 2005;20(10):2958–63.CrossRefPubMed Ulukus EC, Ulukus M, Seval Y, et al. Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis. Hum Reprod. 2005;20(10):2958–63.CrossRefPubMed
25.
go back to reference Ulukus M, Ulukus EC, Goker ENT, et al. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis. Fertil Steril. 2009;91(3):687–93.CrossRefPubMed Ulukus M, Ulukus EC, Goker ENT, et al. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis. Fertil Steril. 2009;91(3):687–93.CrossRefPubMed
26.
go back to reference Gazvani MR, Christmas S, Quenby S, et al. Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease. Hum Reprod. 1998;13(7):1957–61.CrossRefPubMed Gazvani MR, Christmas S, Quenby S, et al. Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease. Hum Reprod. 1998;13(7):1957–61.CrossRefPubMed
Metadata
Title
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
Authors
Bicheng Yang
Liqun Wang
Xiaoju Wan
Yunjun Li
Xiaohong Yu
Yunna Qin
Yong Luo
Feng Wang
Ouping Huang
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2017
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-017-0474-z

Other articles of this Issue 1/2017

BMC Women's Health 1/2017 Go to the issue